Company

Saniona

As of the edition of 20 October 2026, Saniona runs 2 drugs; it is on route A at 3 targets and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Went quiet1
Status not established1
Total2

Where it needs a new molecule

Route A at 3 targets, route B at 0 targets.

Three of its 3 rows, by target and route
TargetRoute
SLC6A3 Sodium-dependent dopamine transporterRoute A
SLC6A2 Sodium-dependent noradrenaline transporterRoute A
SLC6A4 Sodium-dependent serotonin transporterRoute A

All 3 rows on route A or B

In the product

3 company-target rows on route A or B; 0 are not shown here, and no score is.

Where its trials are

  • Hormones: 1 trials led
  • Nutrition and metabolism: 1 trials led